Kalani L. Raphael
No Rating Available
(Learn About Our Rating System)

Kalani L. Raphael, MD, MS

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Nephrology
50 N Medical Dr
Salt Lake City , UT 84132
Get Directions

  • Dr. Raphael received his undergraduate degree in Biology from Gonzaga University and his medical degree from the University of Hawai'i John A. Burns School of Medicine. He completed Internal Medicine and Nephrology training at the University of Utah and has been on the Faculty since 2009. Dr. Raphael is a specialist in disorders of the kidney, electrolytes, and high blood pressure.

    Specialties

    Board Certification

    American Board of Internal Medicine (Sub: Nephrology)
    American Board of Internal Medicine (Internal Medicine)

  • Dr. Raphael received his undergraduate degree in Biology from Gonzaga University and his medical degree from the University of Hawai'i John A. Burns School of Medicine. He completed Internal Medicine and Nephrology training at the University of Utah and has been on the Faculty since 2009. Dr. Raphael is a specialist in disorders of the kidney, electrolytes, and high blood pressure.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Professor
    Academic Divisions Nephrology & Hypertension
    Board Certification
    American Board of Internal Medicine (Sub: Nephrology)
    American Board of Internal Medicine (Internal Medicine)

    Education history

    Undergraduate Biology - Gonzaga University B.S.
    Professional Medical Medicine - University of Hawai'i John A. Burns School of Medicine M.D.
    Internship Internal Medicine - University of Utah School of Medicine Intern
    Residency Internal Medicine - University of Utah School of Medicine Resident
    Chief Resident Internal Medicine - University of Utah School of Medicine Chief Resident
    Research Fellow Nephrology - University of Utah School of Medicine Research Fellow
    Fellowship Nephrology - University of Utah School of Medicine Clinical Fellow
    Graduate Training Clinical Investigation - University of Utah M.Sci.

    Selected Publications

    Journal Article

    1. Raphael KL, Beddhu S (2015). Hypertension and Polypharmacy in Elderly Nursing Home Residents: When Less is More. Am J Kidney Dis, 66(4), 561-3.
    2. Raphael KL (2015). Approach to the treatment of chronic metabolic acidosis in chronic kidney disease. Am J Kidney Dis, 67(4), 696-702.
    3. Raphael KL (2019). Metabolic Acidosis in CKD: Core Curriculum 2019. Am J Kidney Dis, 74(2), 263-275. (Read full publication)
    4. Krishnamurthy VR, Baird BC, Wei G, Greene T, Raphael K, Beddhu S (2011). Associations of serum alkaline phosphatase with metabolic syndrome and mortality. Am J Med, 124(6), 566.e1-7. (Read full publication)
    5. Raphael KL, Strait KA, Stricklett PK, Baird BC, Piontek K, Germino GG, Kohan DE (2009). Effect of pioglitazone on survival and renal function in a mouse model of polycystic kidney disease. Am J Nephrol, 30(5), 468-73. (Read full publication)
    6. Raphael KL, Wei G, Greene T, Baird BC, Beddhu S (2012). Cognitive function and the risk of death in chronic kidney disease. Am J Nephrol, 35(1), 49-57. (Read full publication)
    7. Jotwani VK, Lee AK, Estrella MM, Katz R, Garimella PS, Malhotra R, Rifkin DE, Ambrosius W, Freedman BI, Cheung AK, Raphael KL, Drawz P, Neyra JA, Oparil S, Punzi H, Shlipak MG, Ix JH, for the SPRINT Research Group. (2019). Urinary Biomarkers of Tubular Damage Are Associated with Mortality but Not Cardiovascular Risk among Systolic Blood Pressure Intervention Trial Participants with Chronic Kidney Disease. Am J Nephrol, 49(5), 346-355. (Read full publication)
    8. Raphael KL, Carroll D, Murray J, Greene T, Beddhu S (2017). Urine ammonium predicts clinical outcomes in hypertensive kidney disease. J Am Soc Nephrol, 28(8), 2483-2490.
    9. Isakova T, Ix JH, Sprague SM, Raphael KL, Fried L, Gassman JJ, Raj D, Cheung AK, Kusek JW, Flessner MF, Wolf M, Block GA. (05/12/2015). Rationale and Approaches to Phosphate and Fibroblast Growth Factor 23 Reduction in CKD. J Am Soc Nephrol.
    10. Ix JH, Isakova T, Larive B, Raphael KL, Raj DS, Cheung AK, Sprague SM, Fried LF, Gassman JJ, Middleton JP, Flessner MF, Block GA, Wolf (2019). Effects of Nicotinamide and Lanthanum Carbonate on Serum Phosphate and Fibroblast Growth Factor-23 in CKD: The COMBINE Trial. Journal of the American Society of Nephrology, 30(6), 1096-1108. (Read full publication)
    11. Louie JM, Raphael KL, Barker (2015). Levetiracetam Use With Continuous Renal Replacement Therapy. The Annals of pharmacotherapy, 49(9), 1079-80.
    12. Lee AK, Katz R, Jotwani V, Garimella PS, Ambrosius WT, Cheung AK, Gren LH, Neyra JA, Punzi H, Raphael KL, Shlipak MG, Ix J (2019). Distinct Dimensions of Kidney Health and Risk of Cardiovascular Disease, Heart Failure, and Mortality. Hypertension (Dallas, Tex., 74(4), HYPERTENSIONAHA11913339. (Read full publication)
    13. Raphael KL, Strait KA, Stricklett PK, Miller RL, Nelson RD, Piontek KB, Germino GG, Kohan D (2009). Inactivation of Pkd1 in principal cells causes a more severe cystic kidney disease than in intercalated cells. Kidney international, 75(6), 626-33. (Read full publication)
    14. Damera S, Raphael KL, Baird BC, Cheung AK, Greene T, Beddhu (2011). Serum alkaline phosphatase levels associate with elevated serum C-reactive protein in chronic kidney disease. Kidney international, 79(2), 228-33. (Read full publication)
    15. Raphael KL, Wei G, Baird BC, Greene T, Beddhu (2011). Higher serum bicarbonate levels within the normal range are associated with better survival and renal outcomes in African Americans. Kidney international, 79(3), 356-62. (Read full publication)
    16. Krishnamurthy VM, Wei G, Baird BC, Murtaugh M, Chonchol MB, Raphael KL, Greene T, Beddhu (2012). High dietary fiber intake is associated with decreased inflammation and all-cause mortality in patients with chronic kidney disease. Kidney international, 81(3), 300-6. (Read full publication)
    17. Kraut JA, Raphael K (2019). Drug removal of gastric acid: a novel treatment of metabolic acidosis. Lancet (London, England), 394(10196), 363-364. (Read full publication)
    18. Raphael KL, Zhang Y, Wei G, Greene T, Cheung AK, Beddhu (2013). Serum bicarbonate and mortality in adults in NHANES III. Nephrology, dialysis, transplantation, 28(5), 1207-13. (Read full publication)
    19. SPRINT Research Grou (2015). A Randomized Trial of Intensive versus Standard Blood-Pressure Control. The New England journal of medicine,
    20. Roos KP, Strait KA, Raphael KL, Blount MA, Kohan D (2012). Collecting duct-specific knockout of adenylyl cyclase type VI causes a urinary concentration defect in mice. American journal of physiology. Renal physiology, 302(1), F78-84. (Read full publication)
    21. Raphael KL, Cheung A (2011). Implications of the Frequent Hemodialysis Network-Daily Trial. Seminars in dialysis, 24(6), 621-8. (Read full publication)
    22. Huston HK, Abramowitz MK, Zhang Y, Greene T, Raphael K (2015). Net endogenous acid production and mortality in NHANES III. Nephrology (Carlton, Vic.), 20(3), 209-215.
    23. Raphael KL, Zhang Y, Ying J, Greene T (2014). Prevalence of and risk factors for reduced serum bicarbonate in chronic kidney disease. Nephrology (Carlton, Vic.), 19(10), 648-54.
    24. Schmidt RL, Straseski JA, Raphael KL, Adams AH, Lehman C (2015). A risk assessment of the Jaffe vs enzymatic method for creatinine measurement in an outpatient population. PloS one,
    25. Filipowicz R, Greene T, Wei G, Cheung AK, Raphael KL, Baird BC, Beddhu (2013). Associations of serum skeletal alkaline phosphatase with elevated C-reactive protein and mortality. Clinical journal of the American Society of Nephrology, 8(1), 26-32. (Read full publication)
    26. Raphael KL, Murphy RA, Shlipak MG, Satterfield S, Huston HK, Sebastian A, Sellmeyer DE, Patel KV, Newman AB, Sarnak MJ, Ix JH, Fried L (2015). Bicarbonate, acid-base status, and mortality in the Health, Aging, and Body Composition Study. Clinical journal of the American Society of Nephrology,
    27. Raphael KL, Gilligan S, Hostetter TH, Greene T, Beddhu (2018). Association between urine ammonium and urine TGF-B1 in CKD. Clinical journal of the American Society of Nephrology, 13(2), 223-230.
    28. Raphael KL, Gilligan S, Ix J (2017). Urine anion gap to predict urine ammonium and related outcomes in kidney disease. Clinical journal of the American Society of Nephrology, 13(2), 205-212.
    29. Lloyd IE, Gallan A, Huston HK, Raphael KL, Miller DV, Revelo MP, Khalighi M (2016). C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcomes. Clinical kidney journal, 9(6), 794-99.
    30. Kraut JA, Raphael K (2021). Assessment of Acid-Base Status: Beyond Serum Bicarbonate. Clinical journal of the American Society of Nephrology, 16(9), 1429-1431. (Read full publication)
    31. Jamshidian MS, Larive B, Gassman J, Raphael KL, Chonchol MB, Ix JH, Ginsberg (2021). Effect of Lanthanum Carbonate on Blood Pressure in CKD. American journal of kidney diseases, 78(2), 312-314. (Read full publication)
    32. Al-Kindi SG, Brook RD, Bhatt U, Brauer M, Cushman WC, Hanson HA, Kostis J, Lash JP, Paine R 3rd, Raphael KL, Rapp S, Tamariz L, Wright JT Jr, Rajagopalan S, SPRINT Research Group (2021). The Benefits of Intensive Versus Standard Blood Pressure Treatment According to Fine Particulate Matter Air Pollution Exposure: A Post Hoc Analysis of SPRINT. Hypertension (Dallas, Tex., 77(3), 813-822. (Read full publication)
    33. Melamed ML, Raphael K (2021). Metabolic Acidosis in CKD: A Review of Recent Findings. Kidney medicine, 3(2), 267-277. (Read full publication)
    34. Wang AA, Cai X, Srivastava A, Prasad PV, Sprague SM, Carr J, Wolf M, Ix JH, Block GA, Chonchol M, Raphael KL, Cheung AK, Raj DS, Gassman JJ, Rahsepar AA, Middleton JP, Fried LF, Sarnari R, Isakova T, Mehta (2021). Abnormalities in Cardiac Structure and Function among Individuals with CKD: The COMBINE Trial. Kidney360, 3(2), 258-268. (Read full publication)
    35. Malhotra R, Katz R, Jotwani V, Agarwal A, Cohen DL, Cushman WC, Ishani A, Killeen AA, Kitzman DW, Oparil S, Papademetriou V, Parikh CR, Raphael KL, Rocco MV, Tamariz LJ, Whelton PK, Wright JT Jr, Shlipak MG, Ix J (2021). Estimated GFR Variability and Risk of Cardiovascular Events and Mortality in SPRINT (Systolic Blood Pressure Intervention Trial). American journal of kidney diseases, 78(1), 48-56. (Read full publication)
    36. Xiang J, Morgenstern H, Li Y, Steffick D, Bragg-Gresham J, Panapasa S, Raphael KL, Robinson BM, Herman WH, Saran (2020). Incidence of ESKD Among Native Hawaiians and Pacific Islanders Living in the 50 US States and Pacific Island Territories. American journal of kidney diseases, 76(3), 340-349.e1. (Read full publication)
    37. Ginsberg C, Katz R, Chonchol MB, Bullen AL, Raphael KL, Zhang WR, Ambrosius WT, Bates JT, Neyra JA, Killeen AA, Punzi H, Shlipak MG, Ix J (2020). The Effects of Intensive Blood Pressure Lowering on Markers of Mineral Metabolism in Persons with CKD in SPRINT. Clinical journal of the American Society of Nephrology, 15(6), 852-854. (Read full publication)
    38. Srivastava A, Cai X, Lee J, Li W, Larive B, Kendrick C, Gassman JJ, Middleton JP, Carr J, Raphael KL, Cheung AK, Raj DS, Chonchol MB, Fried LF, Block GA, Sprague SM, Wolf M, Ix JH, Prasad PV, Isakova (2020). Kidney Functional Magnetic Resonance Imaging and Change in eGFR in Individuals with CKD. Clinical journal of the American Society of Nephrology, 15(6), 776-783. (Read full publication)
    39. Gardner J, Tuttle K, Raphael K (2020). Influence of Medications Containing Acid Salts on Serum Bicarbonate in CKD. Kidney360, 1(5), 330-336. (Read full publication)
    40. Malhotra R, Katz R, Jotwani V, Ambrosius WT, Raphael KL, Haley W, Rastogi A, Cheung AK, Freedman BI, Punzi H, Rocco MV, Ix JH, Shlipak M (2020). Urine Markers of Kidney Tubule Cell Injury and Kidney Function Decline in SPRINT Trial Participants with CKD. Clinical journal of the American Society of Nephrology, 15(3), 349-358. (Read full publication)
    41. Raphael KL, Isakova T, Ix JH, Raj DS, Wolf M, Fried LF, Gassman JJ, Kendrick C, Larive B, Flessner MF, Mendley SR, Hostetter TH, Block GA, Li P, Middleton JP, Sprague SM, Wesson DE, Cheung A (2020). A Randomized Trial Comparing the Safety, Adherence, and Pharmacodynamics Profiles of Two Doses of Sodium Bicarbonate in CKD: the BASE Pilot Trial. Journal of the American Society of Nephrology, 31(1), 161-174. (Read full publication)
    42. Ginsberg C, Craven TE, Chonchol MB, Cheung AK, Sarnak MJ, Ambrosius WT, Killeen AA, Raphael KL, Bhatt UY, Chen J, Chertow GM, Freedman BI, Oparil S, Papademetriou V, Wall BM, Wright CB, Ix JH, Shlipak MG, SPRINT Research Group (2018). PTH, FGF23, and Intensive Blood Pressure Lowering in Chronic Kidney Disease Participants in SPRINT. Clinical journal of the American Society of Nephrology, 13(12), 1816-1824. (Read full publication)
    43. Frodsham SG, Yu Z, Lyons AM, Agarwal A, Pezzolesi MH, Dong L, Srinivas TR, Ying J, Greene T, Raphael KL, Smith KR, Pezzolesi M (2019). The Familiality of Rapid Renal Decline in Diabetes. Diabetes, 68(2), 420-429. (Read full publication)
    44. Prasad PV, Li W, Raj DS, Carr J, Carr M, Thacker J, Li LP, Wang C, Sprague SM, Ix JH, Chonchol M, Block G, Cheung AK, Raphael K, Gassman J, Wolf M, Fried LF, Isakova T, CKD Optimal Management with BInders and NicotinamidE (COMBINE) study group (2018). Multicenter Study Evaluating Intrarenal Oxygenation and Fibrosis Using Magnetic Resonance Imaging in Individuals With Advanced CKD. Kidney international reports, 3(6), 1467-1472. (Read full publication)
    45. Raphael KL, Kraut J (2021). Assessing Acid-Base Status in Patients With CKD: Does Measurement of Blood pH Matter?. American journal of kidney diseases, 77(1), 9-11. (Read full publication)
    46. Aitaoto N, Raphael K (2020). Haemodialysis in Samoa: A model for other Pacific nations. The Lancet regional health. Western Pacific, 6, 100071. (Read full publication)
    47. Raphael KL, Shihab F (2017). Acidosis and Kidney Allograft Survival. Journal of the American Society of Nephrology, 28(6), 1672-1674. (Read full publication)
    48. Raphael KL, Greene T, Wei G, Bullshoe T, Tuttle K, Cheung AK, Beddhu (2020). Sodium Bicarbonate Supplementation and Urinary TGF-ß1 in Nonacidotic Diabetic Kidney Disease: A Randomized, Controlled Trial. Clinical journal of the American Society of Nephrology, 15(2), 200-208. (Read full publication)
    49. SPRINT Research Group, Lewis CE, Fine LJ, Beddhu S, Cheung AK, Cushman WC, Cutler JA, Evans GW, Johnson KC, Kitzman DW, Oparil S, Rahman M, Reboussin DM, Rocco MV, Sink KM, Snyder JK, Whelton PK, Williamson JD, Wright JT Jr, Ambrosius W (2021). Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. The New England journal of medicine, 384(20), 1921-1930. (Read full publication)
    50. Kurella Tamura M, Gaussoin S, Pajewski NM, Zaharchuk G, Freedman BI, Rapp SR, Auchus AP, Haley WE, Oparil S, Kendrick J, Roumie CL, Beddhu S, Cheung AK, Williamson JD, Detre JA, Dolui S, Bryan RN, Nasrallah IM, SPRINT Research Grou (2022). Kidney Disease, Hypertension Treatment, and Cerebral Perfusion and Structure. American journal of kidney diseases, 79(5), 677-687.e1. (Read full publication)
    51. Raphael K (2022). Structural Racism in USRDS: A Native Hawaiian Perspective. American journal of kidney diseases, 80(3), 422. (Read full publication)
    52. Uribarri J, Goldfarb DS, Raphael KL, Rein JL, Asplin J (2022). Beyond the Urine Anion Gap: In Support of the Direct Measurement of Urinary Ammonium. American journal of kidney diseases, 80(5), 667-676. (Read full publication)
    53. Azim A, Murray J, Beddhu S, Raphael K (2022). Urinary Sulfate, Kidney Failure, and Death in CKD: The African American Study of Kidney Disease and Hypertension. Kidney360, 3(7), 1183-1190. (Read full publication)
    54. Bullen AL, Ascher SB, Scherzer R, Garimella PS, Katz R, Hallan SI, Cheung AK, Raphael KL, Estrella MM, Jotwani VK, Malhotra R, Seegmiller JC, Shlipak MG, Ix J (2022). Markers of Kidney Tubular Secretion and Risk of Adverse Events in SPRINT Participants with CKD. Journal of the American Society of Nephrology, 33(10), 1915-1926. (Read full publication)
    55. Gruzdys V, Cahoon K, Pearson L, Raphael K (2022). Measurement of Urinary Ammonium Using a Commercially Available Plasma Ammonium Assay. Kidney360, 3(5), 926-932. (Read full publication)
    56. Melamed ML, Raphael K (2023). Safety of Alkalinization in CKD. Clinical journal of the American Society of Nephrology, 18(4), 433-434. (Read full publication)
    57. Ascher SB, Shlipak MG, Katz R, Bullen AL, Scherzer R, Hallan SI, Cheung AK, Raphael KL, Estrella MM, Jotwani VK, Seegmiller JC, Ix JH, Garimella P (2022). Estimated Kidney Tubular Secretion and Kidney, Cardiovascular, and Mortality Outcomes in CKD: The Systolic Blood Pressure Intervention Trial. Kidney medicine, 4(12), 100546. (Read full publication)
    58. Fong P, Wusirika R, Rueda J, Raphael KL, Rehman S, Stack M, de Mattos A, Gupta R, Michels K, Khoury FG, Kung V, Andeen N (2022). Increased Rates of Supplement-Associated Oxalate Nephropathy During COVID-19 Pandemic. Kidney international reports, 7(12), 2608-2616. (Read full publication)
    59. Ravikumar NPG, Pao AC, Raphael K (2022). Acid-Mediated Kidney Injury Across the Spectrum of Metabolic Acidosis. Advances in chronic kidney disease, 29(4), 406-415. (Read full publication)
    60. Dobre M, Pajewski NM, Beddhu S, Chonchol M, Hostetter TH, Li P, Rahman M, Servilla K, Weiner DE, Wright JT, Raphael KL, SPRINT Research Grou (2020). Serum bicarbonate and cardiovascular events in hypertensive adults: results from the Systolic Blood Pressure Intervention Trial. Nephrology, dialysis, transplantation, 35(8), 1377-1384. (Read full publication)
    61. Di Iorio BR, Bellasi A, Raphael KL, Santoro D, Aucella F, Garofano L, Ceccarelli M, Di Lullo L, Capolongo G, Di Iorio M, Guastaferro P, Capasso G, UBI Study Grou (2019). Treatment of metabolic acidosis with sodium bicarbonate delays progression of chronic kidney disease: the UBI Study. Journal of nephrology, 32(6), 989-1001. (Read full publication)
    62. Na'ai D, Raphael K (2019). CKD in Native Hawaiians and Pacific Islanders: Trouble in Paradise. Clinical journal of the American Society of Nephrology, 14(11), 1661-1663. (Read full publication)
    63. Raphael K (2019). The Dietary Approaches to Stop Hypertension (DASH) diet in chronic kidney disease: should we embrace it?. Kidney international, 95(6), 1296-1298. (Read full publication)
    64. Chen W, Newman AB, Fried LF, Rifkin DE, Shlipak MG, Sarnak MJ, Katz R, Madero M, Raphael KL, Bushinsky DA, Ix J (2018). Relationship of acid-base status with arterial stiffness in community-living elders: the Health ABC Study. Nephrology, dialysis, transplantation, 33(9), 1572-1579. (Read full publication)
    65. Raphael KL, Yee (2018). It Is Really Time for Ammonium Measurement. Advances in chronic kidney disease, 25(4), 297-300. (Read full publication)
    66. Dobre M, Gaussoin SA, Bates JT, Chonchol MB, Cohen DL, Hostetter TH, Raphael KL, Taylor AA, Lerner AJ, Wright JT Jr, Rahman M, SPRINT Research Grou (2018). Serum Bicarbonate Concentration and Cognitive Function in Hypertensive Adults. Clinical journal of the American Society of Nephrology, 13(4), 596-603. (Read full publication)
    67. Raphael KL, Ix J (2018). Correlation of Urine Ammonium and Urine Osmolal Gap in Kidney Transplant Recipients. Clinical journal of the American Society of Nephrology, 13(4), 638-640. (Read full publication)
    68. Raphael K (2018). Metabolic Acidosis and Subclinical Metabolic Acidosis in CKD. Journal of the American Society of Nephrology, 29(2), 376-382. (Read full publication)
    69. Gilligan S, Raphael K (2017). Hyperkalemia and Hypokalemia in CKD: Prevalence, Risk Factors, and Clinical Outcomes. Advances in chronic kidney disease, 24(5), 315-318. (Read full publication)
    70. Beddhu S, Chen X, Wei G, Raj D, Raphael KL, Boucher R, Chonchol MB, Murtaugh MA, Greene (2017). Associations of Protein-Energy Wasting Syndrome Criteria With Body Composition and Mortality in the General and Moderate Chronic Kidney Disease Populations in the United States. Kidney international reports, 2(3), 390-399. (Read full publication)
    71. Whitaker M, Aguirre MC, Gutierrez Chavez M, Beaulieu E, Arones YB, Gershenoff D, Hinton K, Klein N, Munezerou Uwizeye J, Napia E, Ramos C, Tavake-Pasi OF, Villalta J, Wolfsfeld C, Witte B, Maxfield E, Raphael K, Simmons DL, Clark L, Sher T, Smith TW, Baucom K (2023). Couple-based lifestyle intervention to prevent type 2 diabetes: protocol for a randomised pilot trial. BMJ open, 13(2), e068623. (Read full publication)
    72. Webster L, Larive B, Gassman J, Bullen A, Weisbord SD, Palevsky PM, Fried LF, Raphael K, Isakova T, Ix J (2020). A Simple Equation to Estimate Urinary Flow Rate Using Urine Creatinine. American journal of nephrology, 51(5), 395-400. (Read full publication)
    73. Lehman CM, Pearson L, Salmond J, Raphael K, Schmidt R (2019). A Reflex Protocol for Creatinine Testing Reduces Costs and Maintains Patient Safety. Laboratory medicine, 50(2), 202-207. (Read full publication)
    74. Rondina MT, Raphael K, Pendleton R, Sande M (2006). Abdominal aortitis due to Streptococcus pneumoniae and Enterobacter aerogenes: a case report and review. Journal of general internal medicine, 21(7), C1-3. (Read full publication)
    75. Raphael KL, Katz R, Larive B, Kendrick C, Isakova T, Sprague S, Wolf M, Raj DS, Fried LF, Gassman J, Hoofnagle A, Cheung AK, Ix J (2024). Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial. Journal of the American Society of Nephrology, 35(1), 57-65. (Read full publication)
    76. Azim A, Hu B, Gilligan S, Sarwal A, Hartsell S, Pandya V, Raphael K (2023). How I Evaluate a High Anion Gap Metabolic Acidosis. Clinical journal of the American Society of Nephrology, 19(4), 525-527. (Read full publication)
    77. Taparra K, Purdy M, Raphael K (2023). From Ashes to Action - Indigenous Health Perspectives on the L'hain¿ Fires. The New England journal of medicine, 389(17), 1543-1546. (Read full publication)
    78. Pao AC, Shahzad SR, Song S, Ganesan C, Conti S, Leppert J, Cheung AK, Ix JH, Isakova T, Wolf M, Raj DS, Sprague SM, Fried LF, Gassman J, Fong P, Koike S, Raphael K (2023). Response to Alkali Administration in Women and Men With and Without CKD. Kidney medicine, 5(7), 100670. (Read full publication)
    79. Raphael K, Tokeshi (2002). Hyponatremia associated with sertraline and fluoxetine: a case report. Hawaii medical journal, 61(3), 46-7. (Read full publication)
    80. Trujillo J, Alotaibi M, Seif N, Cai X, Larive B, Gassman J, Raphael KL, Cheung AK, Raj DS, Fried LF, Sprague S, Block G, Chonchol M, Middleton JP, Wolf M, Ix JH, Prasad P, Isakova T, Srivastava (2024). Associations of Kidney Functional Magnetic Resonance Imaging Biomarkers with Markers of Inflammation in Individuals with Chronic Kidney Disease. Kidney360, (Read full publication)
    81. Sohn MB, Gao B, Kendrick C, Srivastava A, Isakova T, Gassman JJ, Fried LF, Wolf M, Cheung AK, Raphael KL, Vinales PC, Middleton JP, Pabalan A, Raj DS, Pilot Studies in CKD Consortiu (2023). Targeting Gut Microbiome With Prebiotic in Patients With CKD: The TarGut-CKD Study. Kidney international reports, 9(3), 671-685. (Read full publication)

  • News & Podcasts

    Podcasts